Aizenhawar Jamil Marrogi, MD

Unless otherwise indicated, this information has been self-reported and has not been verified by the Board of Medicine.

Tulane University School Of Medicine - New Orleans LA
Rank: Assistant Professor
Years: 1992-1996

Tulane University School Of Medicine - New Orleans LA
Rank: Associate Professor
Years: 1996-1997

Louisiana State University School Of Medicine In New Orleans - New Orleans LA
Rank: Associate Professor
Years: 1997-1998

Johns Hopkins University School Of Medicine - Baltimore MD
Rank: Associate Professor
Years: 2001-2003

Uniformed Services University Of The Health Sciences F. Edward Hébert School Of Medicine - Bethesda MD
Rank: Associate Professor
Years: 2003-Current

None Reported

Atypical cutaneous lymphocytic infiltrate and a role for quantitative immunohistochemistry and gene rearrangement studies.
Int J Dermatol.
38(10):749-56.
Date: 10 1999

Human mesothelioma samples overexpress both cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (NOS2): in vitro antiproliferative effects of a COX-2 inhibitor.
Cancer Res.
60(14):3696-700.
Date: 07 2000

Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease.
Cancer Res.
60(13):3333-7.
Date: 07 2000

Increased p53 mutation load in nontumorous human liver of wilson disease and hemochromatosis: oxyradical overload diseases
Proc Natl Acad Sci U S A.
97(23):12770-5.
Date: 11 2000

Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma
Clin Cancer Res. 2000
6(12):4739-44.
Date: 12 2000

Polymorphisms in XPD and TP53 and Mutation in Human Lung Cancer.
Carcinogenesis
263:597-604
Date: 06 2005

TP53 Mutation Spectrum in Lung Cancer Are Not Different in Women and Men
Cancer Epidemiol Bio Prev
14:1031-1033
Date: 06 2005

Unlimited access to care: effect on racial disparity and prognostic factors in lung cancer. .
Cancer Epidemiol Bio Prev,
15:25-31
Date: 04 2006

Lung cancer staging: a case for a new T definition.
Annals Thoracic Surgery
82:220-226
Date: 08 2006

p53 tumor suppressor gene mutations in transformed cutaneous T-cell lymphoma: a study of 12 cases.
J Cutan Pathol.
26(8):369-78.
Date: 09 2008

Enewold, L., Zhu, K., Ron, E., Marrogi, A., J., Stojadinovic, A., Peoples, E., G., Devesa, S. prognostic factors in lung cancer. .
Cancer Epidemiol Bio Prev,
18:784-91
Date: 04 2009

4. Enewold L, Zhou J, Devesa SS, Berrington de Gonzalez A, Anderson WF, Zham SH, Stojadinovic A, Peoples GE, Marrogi AJ, Potter JF, McGlynn KA, Zhu K. Thyroid cancer incidence among active duty U.S. military, 1990-2004.
Cancer Epidemiol Biomarkers Prev.
20:2369-76
Date: 08 2011

3. Schwarzenberger, P., Byrne, Gaumer, R., Norton, J., Harrison, J, Marrogi, A. J., Kolls , J. Intra-Tumoral Drug Assessment of Mesothelioma Patients Following Treatment with PA1STK Cells and Ganciclovir.
Can Gen Therapy
18:906-12.
Date: 09 2011

Polymorphisms in XPD and TP53 and Mutation in Human Lung Cancer.
Carcinogenesis
263:597-604
Date: 06 2014

TP53 Mutation Spectrum in Lung Cancer Are Not Different in Women and Men
Cancer Epidemiol Bio Prev
14:1031-1033
Date: 06 2014

Atypical cutaneous lymphocytic infiltrate and a role for quantitative immunohistochemistry and gene rearrangement studies.
Int J Dermatol.
38(10):749-56.
Date: 10 2014